Dosing & Administration
In patients ≥18 years receiving antibacterial drug treatment of CDI who are at high risk for CDI recurrence:
Learn About:
Appropriate patients for ZINPLAVA
Think about adding ZINPLAVA when your patients are receiving antibacterial drug treatment for CDI and have 1 or more of these risk factors:
- - History of CDI in the previous 6 months
- - Patients ≥65 years of age
- - Patients who are immunocompromised
- - Severe CDI (Zar score ≥2)
Add ZINPLAVA: Target toxin B to reduce CDI recurrence
The recommended dose of ZINPLAVA is a single 10-mg/kg dose administered as an IV infusion over 60 minutes.
Add ZINPLAVA at any time during CDI antibiotic treatment

Administration
Find the nearest Infusion center for your patients: